US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

112 deals · US$144bndisclosed · Biotech · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Feb 2025 Instinct Bio Technical Company –Relativity Acquisition SponsorMergerPending225.0Biotech Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Oct 2025 Astria Therapeutics –BioCryst PharmaceuticalsAcquisitionCompleted700.0Biotech+2 Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Oct 2025 Avidity Biosciences –NovartisAcquisitionAnnounced11,000.0Biotech+2 Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side)
Nov 2025 Aptose Biosciences –HS North AmericaAcquisitionAnnounced–Biotech+2 Locust Walk (sell-side)Stikeman Elliott (buy-side)
Dec 2025 MindWave Innovations –Apimeds Pharmaceuticals USMergerCompleted–Biotech+1 Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side)
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 Amicus Therapeutics –BioMarinAcquisitionAnnounced4,800.0Biotech+2 Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Dec 2025 Dynavax Technologies –SanofiAcquisitionAnnounced2,200.0Biotech+1 Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side)
2026 Calytrix Bio –Eli LillyAcquisitionAnnounced1,500.0Biotech Centerview Partners (sell-side)
2026 AttaiBeckley –Eli Lilly and CompanyAcquisitionAnnounced3,800.0Biotech+2 Moelis & Company (sell-side)
2026 FireFly Biologics –J&JAcquisitionAnnounced1,000.0Biotech+1 Centerview Partners (sell-side)
Jan 2026 Dark Blue Therapeutics –AmgenAcquisitionCompleted840.0Biotech+2 Goodwin (sell-side)BofA Securities (sell-side)
Jan 2026 Mersana Therapeutics –Day One BiopharmaceuticalsAcquisitionCompleted–Biotech+2 TD Securities (sell-side)WilmerHale (sell-side)Gordon Dyal & Co. (buy-side)Fenwick & West (buy-side)
Jan 2026 Ventyx Biosciences –Eli Lilly and CompanyAcquisitionAnnounced1,200.0Biotech+2 Jefferies (sell-side)Moelis & Company (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Ropes & Gray (buy-side)
Jan 2026 InduPro Therapeutics –Eli Lilly and CompanyStakeAnnounced–Biotech+2 Freshfields (buy-side)
Jan 2026 RAPT Therapeutics –GSKAcquisitionAnnounced2,200.0Biotech+1 J.P. Morgan (sell-side)Cooley (sell-side)Latham & Watkins (sell-side)Evercore (buy-side)A&O Shearman (buy-side)
Jan 2026 Repare Therapeutics –XenoTherapeuticsAcquisitionCompleted–Biotech+1 Cooley (sell-side)Stikeman Elliott (sell-side)
Feb 2026 PrimeGen US –DT Cloud Star AcquisitionMergerAnnounced1,500.0Biotech+1 A.G.P./Alliance Global Partners (sell-side)Sichenzia Ross Ference Carmel (sell-side)Loeb & Loeb (buy-side)
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced2,400.0Biotech+1 Lazard (sell-side)Goodwin (sell-side)Paul, Weiss (buy-side)
Feb 2026 Avadel Pharmaceuticals –AlkermesSchemeCompleted–Pharma+1 Goldman Sachs (sell-side)Morgan Stanley (sell-side)J.P. Morgan (buy-side)
Feb 2026 Faeth Therapeutics –Sensei BiotherapeuticsAcquisitionCompleted–Biotech+2 Cooley (sell-side)Lucid Capital Markets (buy-side)Sidley Austin (buy-side)
Feb 2026 Arcellx –Gilead SciencesAcquisitionAnnounced7,800.0Biotech+2 Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Morgan Stanley (buy-side)Ropes & Gray (buy-side)Innisfree M&A (buy-side)
Feb 2026 AiCuris Anti-infective Cures AG –Veloxis PharmaceuticalsAcquisitionAnnounced913.0Pharma+1 Gibson Dunn (sell-side)Freshfields (buy-side)
Mar 2026 Transcend Therapeutics –OtsukaAcquisitionAnnounced700.0Biotech+2 Kirkland & Ellis (sell-side)Goodwin (sell-side)Centerview Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (buy-side)
Mar 2026 Cullgen –Gyre TherapeuticsAcquisitionPending300.0Biotech+1 Mintz (sell-side)Moelis & Company (buy-side)Gibson Dunn (buy-side)
Mar 2026 Candid Therapeutics –RallybioAcquisitionPending–Biotech+1 Wedbush Securities (sell-side)Cooley (sell-side)Evercore (buy-side)Citizens JMP (buy-side)Ropes & Gray (buy-side)
Mar 2026 Unleash-owned rights to UIO-524, UIO-525 and UIO-526 Unleash Immuno OncolyticsTransCode TherapeuticsAsset salePending–Biotech+2 Tungsten Advisors
Mar 2026 Lisata Therapeutics –Kuva LabsAcquisitionPending–Biotech+2 Mintz (sell-side)H.C. Wainwright & Co. (sell-side)Goodwin (buy-side)Campaign Management (buy-side)
Mar 2026 Day One Biopharmaceuticals –ServierAcquisitionPending2,500.0Biotech+2 Centerview Partners (sell-side)Fenwick & West (sell-side)Goldman Sachs (buy-side)Baker McKenzie (buy-side)Innisfree M&A (buy-side)
Mar 2026 Pikavation SynnovationNovartisAcquisitionAnnounced2,000.0Biotech+2 Goodwin (sell-side)Centerview Partners (sell-side)
Mar 2026 Ouro Medicines –GileadAcquisitionAnnounced1,675.0Biotech+1 Paul, WeissGoodwin (sell-side)Centerview Partners (buy-side)
Mar 2026 Terns Pharmaceuticals –Merck & Co.AcquisitionAnnounced6,700.0Biotech+2 Centerview Partners (sell-side)Freshfields (sell-side)Jefferies (sell-side)Covington & Burling (buy-side)Gibson Dunn (buy-side)
Mar 2026 Eos SENOLYTIX –PulmatrixMergerAnnounced–Biotech+1 Palladium Capital Group (buy-side)Evolution Venture Partners (sell-side)Wilk Auslander (sell-side)Gemini Valuation Services (buy-side)Haynes Boone (buy-side)
Mar 2026 AnaptysBio outstanding common stock –AnaptysBioBuy-backAnnounced100.0Biotech+1 Piper Sandler (buy-side)
Mar 2026 Kezar Life Sciences –Aurinia PharmaceuticalsAcquisitionAnnounced51.5Biotech+1 TD Securities (sell-side)Cooley (sell-side)
Mar 2026 Apellis Pharmaceuticals –BiogenAcquisitionAnnounced5,600.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)WilmerHale (sell-side)Cravath, Swaine & Moore (buy-side)
Mar 2026 Centessa Pharmaceuticals –Eli Lilly and CompanySchemePending6,300.0Biotech+1 Centerview Partners (sell-side)Jefferies (sell-side)Goodwin (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)
Apr 2026 Modeyso commercial sales royalties Former Oncoceutics Inc. securityholdersHealthCare RoyaltyAsset saleAnnounced–Specialty finance and leasing+3 Latham & Watkins (sell-side)
Apr 2026 Exclusive global rights to TAK-063 (balipodect) Takeda Pharmaceutical Co.Axsome TherapeuticsAsset saleCompleted–Pharma+1 Sidley Austin (buy-side)
Apr 2026 Soleno Therapeutics –Neurocrine BiosciencesAcquisitionCompleted2,900.0Biotech+2 Centerview Partners (sell-side)Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goodwin (sell-side)Goldman Sachs (buy-side)Cooley (buy-side)
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionAnnounced3,150.0Biotech+2 Goodwin (sell-side)J.P. Morgan (sell-side)CMS (sell-side)Centerview Partners (buy-side)Allen & Company (buy-side)Covington & Burling (buy-side)Arnold & Porter (buy-side)Venable (buy-side)
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionAnnounced300.0Biotech+2 Cooley (sell-side)
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerCompleted413.5Biotech+2 Goodwin (sell-side)Sidley Austin (buy-side)Leerink Partners (sell-side)Lucid Capital Markets (buy-side)
Apr 2026 Neurona Therapeutics –UCBAcquisitionAnnounced650.0Biotech+2 Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced7,000.0Biotech+2 Goodwin (sell-side)Jefferies (sell-side)Kirkland & Ellis (buy-side)
Apr 2026 Kashiv BioSciences –Amneal PharmaceuticalsAcquisitionCompleted375.0Biotech+2 J.P. Morgan (sell-side)Holland & Knight (sell-side)Goldman Sachs (buy-side)Richards, Layton & Finger (buy-side)Simpson Thacher & Bartlett (buy-side)Boston Consulting Group (buy-side)
Apr 2026 Ajax Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced2,300.0Biotech+2 Cooley (sell-side)Kirkland & Ellis (sell-side)Ropes & Gray (buy-side)
Apr 2026 XOMA Royalty –Ligand PharmaceuticalsAcquisitionCompleted739.0Specialty finance and leasing+2 Leerink Partners (sell-side)H.C. Wainwright & Co. (sell-side)Gibson Dunn (sell-side)Stifel (buy-side)Citi (buy-side)Paul Hastings (buy-side)Collected Strategies (buy-side)
Apr 2026 KalVista Pharmaceuticals –Chiesi GroupAcquisitionCompleted1,900.0Pharma+2 Centerview Partners (sell-side)Kirkland & Ellis (sell-side)Fenwick & West (sell-side)Jefferies (sell-side)Lazard (buy-side)Ropes & Gray (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built